Latest Breaking News On - Torno capital - Page 1 : comparemela.com

Pilgrim s Pride Co (NASDAQ:PPC) Receives $32 00 Average Target Price from Brokerages

Pilgrim’s Pride Co. (NASDAQ:PPC – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the four analysts that are covering the company, Marketbeat reports. One analyst has rated the stock with a hold rating and three have issued a buy rating on the company. The average twelve-month price objective among brokerages […]

United statesFabio sandriSecurities exchange commissionGoldman sachs groupPilgrim pride company profilePilgrim pride corporationPricet rowe associates incTorno capitalCapital partnersPilgrim pride coGet free reportExchange commissionEmployees retirement systemGet freePride corporationPride daily

Innoviz Technologies (INVZ) Overweight Rating Reiterated at JPMorgan Chase & Co

Innoviz Technologies (NASDAQ:INVZ – Get Free Report)‘s stock had its “overweight” rating reaffirmed by stock analysts at JPMorgan Chase & Co. in a report issued on Tuesday, Benzinga reports. They currently have a $7.00 price objective on the stock, down from their previous price objective of $13.00. JPMorgan Chase & Co.‘s target price indicates a […]

Torno capitalInnoviz technologies ltdGoldman sachs groupAdvisor groupJpmorgan chase coInnoviz technologiesGet free reportTechnologies stock downGate managerInnoviz technologies daily

Pacira BioSciences (NASDAQ:PCRX) Coverage Initiated by Analysts at JPMorgan Chase & Co

Pacira BioSciences (NASDAQ:PCRX) Coverage Initiated by Analysts at JPMorgan Chase & Co
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesNew zealand generalNew zealandPacira biosciencesRaymond jamesTorno capitalGroup wealth managementNeedham companySecurities exchange commissionCapital partnersJpmorgan chase coPacira biosciences incWellington management groupInvestment groupRoyal bankFree report

Pacira BioSciences, Inc (NASDAQ:PCRX) Director Gary W Pace Sells 90,000 Shares

Pacira BioSciences, Inc (NASDAQ:PCRX) Director Gary W Pace Sells 90,000 Shares
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesPacira biosciencesPacira biosciences company profileGroup wealth managementFinancial freedomPacira biosciences incNeedham companyTorno capitalChina universal asset management coRoyal bankGet free reportDirector garyIvy capital managementWealth managementUniversal asset managementPacira biosciences daily

Brokerages Set indie Semiconductor, Inc (NASDAQ:INDI) PT at $13 50

indie Semiconductor, Inc. (NASDAQ:INDI – Get Free Report) has received an average recommendation of “Buy” from the seven ratings firms that are currently covering the firm, MarketBeat Ratings reports. Seven equities research analysts have rated the stock with a buy rating. The average twelve-month price target among analysts that have issued a report on the […]

United statesDonald mcclymontThomas schillerCraig hallumAsia pacificGroup plcTorno capitalSemiconductor stock performanceAmerican international group incSemiconductor dailyPricet rowe associates incSemiconductor incGet free reportMarketbeat ratingsSemiconductor stockInternational group